Categories: 心血管病

Combining Antiplatelets and Anticoagulants Risky合用抗血小板药和抗凝药危险

A prospective study concluded that concomitant antiplatelet therapy (APT) should not be prescribed with an oral anticoagulant in patients with stable coronary artery disease (CAD). The study included 4184 outpatients who were free from any myocardial infarction (MI) or coronary revascularization for >1 year at inclusion. Follow-up was performed at 2 years. Major bleeding events are rare but are an independent predictor of death. The increased risk of bleeding associated with vitamin K antagonist (VKA) treatment was particularly evident when VKA was combined with an APT. In contrast, the risk of cardiovascular death, MI, or nonhemorrhagic stroke did not differ in patients who received VKA + APT versus patients on VKA alone. There is no evidence that inhibition of platelet activation provided anything but harm in patients with atrial fibrillation who did not have CAD. Source: http://content.onlinejacc.org/一项前瞻性研究的结论是,对病情稳定的冠心病(CAD)不应该联合应用抗血小板治疗(APT)与一种口服抗凝药。该研究共纳入4184名〉1年无任何心肌梗死(MI)或冠状动脉血管重建术的门诊病人。 两年时进行了随访。大出血事件很少却是死亡的独立预测因素。当维生素K拮抗剂(VKA)与APT合用时,与VKA治疗相关的出血风险增加尤为明显。与此相反,心血管病死亡,心肌梗死或非出血性卒中的风险在VKA + APT与VKA单独治疗的患者中没有显着差异。没有任何证据表明抑制血小板活化对没有CAD的房颤患者有益,反而有害。来源:http://content.onlinejacc.org/

hyangiu

近期博文

4:3间歇性禁食减肥效果优于每日热量限制

一项美国随机临床试验发现,对于…

3 天 ago

新型降糖药对老年二型糖尿病患者心血管病的效果比较

一项丹麦全国性队列研究提供的真…

1 周 ago

非手术与非介入疗法对腰痛的疗效

基于安慰剂对照的随机试验,一项…

2 周 ago

服用他汀类药物与肝癌及肝病进展风险降低有关

一项美国队列研究提示,服用他汀…

2 周 ago

颈动脉斑块的临床意义及其与年龄和性别的关系

一项美国队列研究提示,在没有临…

3 周 ago

用植物油取代黄油可提高生存率

一项基于美国人群的前瞻性队列研…

4 周 ago

This website uses cookies.